TrialHematology/oncology and stem cell therapy2018

Presence of fluorescent in situ hybridization abnormalities is associated with plasma cell burden in light chain amyloidosis.

Lindsay Hammons et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.